Literature Highlights - February 2023

long term economic burden, neurologic, psychiatric, international, multi-ethnic, SLE, criteria, classification, damage, lupus, prognosis, autoimmune diseases, biological therapy, glucocorticoids, systemic lupus erythematosus, health-related quality of life, interferon signature, SLEDAI, transcriptomic, patient-reported outcome, fatigue, disease activity, mediation analysis

more…

Clear Search

Showing 2 results for “Amoura Z”.

July 2022
October 2021

Two-Year, Randomised, Controlled Trial of Belimumab in Lupus Nephritis

N Engl J Med. 2020;383(12):1117–28.

LN occurs in 25–60% of patients with SLE. However, patients with LN are often excluded from clinical trials of SLE therapies.

more…